AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19249182
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg infused over 1 h every 8 h for complicated intra-abdominal infections
Trial: 19249182
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg infused over 4 h every 8 h for hospital-acquired pneumonia
Trial: 12957743
Drug: Metronidazole 750
RxNorm normalized name: metronidazole 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 750 mg daily in divided doses for 14 days
Trial: 16962882
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg dapoxetine
Trial: 16962882
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg dapoxetine
Trial: 29313486
Drug: Ivermectin (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (0.15 mg/kg)
Trial: 21197713
Drug: Valganciclovir (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir (900 mg) once daily for up to 200 days
Trial: 21197713
Drug: Valganciclovir (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir (900 mg) once daily for up to 100 days
Trial: 18438718
Drug: ACEI/ARB discontinuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI/ARB discontinuation group
Trial: 14982549
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of antiretroviral medication
Trial: 14982549
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of drugs or alcohol in the previous 30 days
Trial: 11314834
Drug: Pethidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine 0.5 mg/kg
Trial: 9388088
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal (3766 J [900 calories], 50 g of fat)
Trial: 9388088
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal (3766 J [900 calories], 0 g of fat)
Trial: 9388088
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal with vitamins C (1 g) and E (800 IU)
Trial: 9388088
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal with vitamins C (1 g) and E (800 IU)
Trial: 3147423
Drug: Lignocaine injections
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine injections
Trial: 28038497
Drug: Routine oral
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine oral instructions (Control)
Trial: 26705931
Drug: High-Dose Trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Dose Trivalent Inactivated Influenza Vaccine (60 μg HA/strain/dose)
Trial: 26705931
Drug: Standard-Dose Trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-Dose Trivalent Inactivated Influenza Vaccine (15 μg HA/strain/dose)
Trial: 19515542
Drug: Dipeptidyl Peptidase‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipeptidyl Peptidase‐4 (DPP‐4) inhibitors
Trial: 19515542
Drug: DPP‐4 inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPP‐4 inhibitors
Trial: 10645918
Drug: Abciximab plus
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab plus reduced-dose tPA (combination therapy)
Trial: 8785148
Drug: Vecuronium 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.05 mg kg‐1
Trial: 1558994
Drug: Topical alpha-interferon
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical alpha-interferon ointment with dimethyl sulfoxide
Trial: 28864073
Drug: Intensity-modulated radiotherapy
RxNorm normalized name: California intense cedar pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity-modulated radiotherapy (IMRT) planned using pre-induction chemotherapy images (group A)
Trial: 28864073
Drug: Intensity-modulated radiotherapy
RxNorm normalized name: California intense cedar pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity-modulated radiotherapy (IMRT) planned using post-induction chemotherapy images (group B)
Trial: 26967222
Drug: SR 23
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 23 mg/day donepezil
Trial: 26967222
Drug: IR 10
RxNorm normalized name: Oralair 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IR 10 mg/day donepezil
Trial: 22849758
Drug: Progesterone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (300 mg at h.s. daily)
Trial: 24347664
Drug: Defibrillator-only therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrillator-only therapy
Trial: 15179643
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (Dysport) injections (200U each into medial and lateral heads of gastrocnemius and 400U each into tibialis posterior) and Functional Electric Stimulation (FES) used daily for 16 weeks
Trial: 11453318
Drug: Almitrine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (50 mg bid)
Trial: 11453318
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (20 mg tid)
Trial: 11453318
Drug: Almitrine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (50 mg bid) and Medroxyprogesterone acetate (20 mg tid)
Trial: 9870483
Drug: Bicarbonate solution
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate solution (38 mmol/l of bicarbonate)
Trial: 9870483
Drug: Bicarbonate/lactate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate/lactate solution (25 mmol/l bicarbonate and 15 mmol/l lactate)
Trial: 9870483
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution (40 mmol/l lactate)
Trial: 1358607
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg three times daily
Trial: 27235677
Drug: 20‐mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mL 1% buffered lidocaine four‐site PCB with a 3‐min wait prior to cervical dilation
Trial: 27235677
Drug: 20‐mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mL 1% buffered lidocaine four‐site PCB with no wait prior to cervical dilation
Trial: 27235677
Drug: 20‐mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mL 1% buffered lidocaine four‐site PCB (four‐site)
Trial: 27235677
Drug: 20‐mL 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mL 1% buffered lidocaine two‐site PCB
Trial: 18356335
Drug: Sodium iron
RxNorm normalized name: Sodium iron EDTA
DrugBank: Sodium feredetate (DB13381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium iron EDTA (NaFeEDTA) at 10 mg/kg flour
Trial: 18356335
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate at 20 mg/kg flour
Trial: 18356335
Drug: Electrolytic iron
RxNorm normalized name: electrolytic iron
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Electrolytic iron at 35 mg/kg flour
Trial: 8035590
Drug: Pseudoephedrine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (60 mg)
Trial: 7614644
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus Dexamethasone (20 micrograms.kg‐1 and 8 mg)
Trial: 7211827
Drug: Control centers
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control centers (CC)
Trial: 25026508
Drug: Breathing retraining
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breathing retraining plus manual therapy (MT), n=30
Trial: 25026508
Drug: Breathing retraining
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breathing retraining (standard treatment), n=30
Trial: 17570848
Drug: Artemether plus
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Artemether plus lumefantrine (Coartem; four doses)
Trial: 17570848
Drug: Artemether plus
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Artemether plus lumefantrine (Coartem; six doses)
Trial: 11820045
Drug: 10% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% carbamide peroxide gel with 3% potassium nitrate and 0.11 fluoride ion
Trial: 11820045
Drug: 10% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% carbamide peroxide gel only (control)
Trial: 9924466
Drug: 150 IU
RxNorm normalized name: Follitropin Beta 150 IU/0.5 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 IU oral nHuIFN-alpha/day
Trial: 3041248
Drug: Hormone treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone treatment (oestrogen and norethisterone acetate)
Trial: 23652778
Drug: Furosemide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20 mg intravenous injection)
Trial: 17627814
Drug: Oral DHEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral DHEA (50mg capsules, 2 capsules daily for 14 days)
Trial: 17627814
Drug: Percutaneous DHEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous DHEA (4g of 10% DHEA cream or gel daily for 14 days)
Trial: 11748599
Drug: Eye Movement
RxNorm normalized name: JOINT MOVEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eye Movement Desensitization and Reprocessing (EMDR) treatment
Trial: 9449495
Drug: Aerosol beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol beclomethasone dipropionate spray (84 microg four times per day)
Trial: 9449495
Drug: Sustained-release theophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release theophylline (doses adjusted for optimum control, twice per day)
Trial: 2212369
Drug: dual pathway
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dual pathway sequential pulsing
Trial: 25733317
Drug: ivabradine (10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine (10-15 mg/day for 6 months)
Trial: 21700416
Drug: Control period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control period (ordinary treatment)
Trial: 19565732
Drug: Acupoint application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint application of Chinese medicine at Dazhui (GV 14), Feishu (BL 13), Gaohuang (BL 43), Danzhong (CV 17), Qihai (CV 6)
Trial: 11373411
Drug: Lenercept (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenercept (0.125 mg/kg intravenous)
Trial: 9266384
Drug: New amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New amino acid formulation and treatment products
Trial: 24737678
Drug: Thioguanine treatment
RxNorm normalized name: Thioguanine
DrugBank: Tioguanine (DB00352)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioguanine treatment arm (CCG‐1952 clinical trial)
Trial: 24737678
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MTHFR and TPMT variant genotypes
Trial: 22420475
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mL)
Trial: 22420475
Drug: Morphine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (1 mL)
Trial: 16218969
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (1 mL)
Trial: 11429337
Drug: Fenoldopam infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam infusion at 1.3 +/- 0.4 microg.kg(-1).min(-1)
Trial: 11429337
Drug: Concurrent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent infusion of phenylephrine
Trial: 9531030
Drug: Desirudin (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desirudin (10, 15 or 20 mg b.i.d.)
Trial: 2737311
Drug: Intramuscular analgesics
RxNorm normalized name: ANALGESIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular analgesics given at fixed hours (methadone 10 mg i.m. every 12 h for days 1-3; sodium diclofenac 75 mg i.m. every 12 h for days 4-7)
Trial: 2737311
Drug: Intramuscular analgesics
RxNorm normalized name: ANALGESIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular analgesics given at fixed hours
Trial: 2737311
Drug: Drugs 'on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs 'on demand' or not treated at all
Trial: 342618
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza A/New Jersey/76 virus vaccines (200, 400, or 800 chick cell-agglutinating units)
Trial: 342618
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza A/New Jersey/76 virus vaccines (all dosages)
Trial: 342618
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza A/New Jersey/76 virus vaccines
Trial: 30472196
Drug: NT-proBNP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-proBNP levels < 45 ng/L
Trial: 25735317
Drug: Bevacizumab (B)
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab (B) added to standard chemotherapy (CT)
Trial: 25735317
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (CT) only
Trial: 24968500
Drug: Injection lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection lignocaine (preservative free) 1.5 mg/kg i.v.
Trial: 24968500
Drug: Oral pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral pregabalin 150 mg capsule
Trial: 19233341
Drug: Any aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Any aspirin use (self-selected)
Trial: 8080611
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 400 micrograms BD for eight weeks
Trial: 8080611
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for four weeks
Trial: 2947537
Drug: Cefoperazone 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone 0.5 g
Trial: 2947537
Drug: Cefoperazone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone 1.0 g
Trial: 2947537
Drug: Spectinomycin 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectinomycin 2.0 g
Trial: 20299470
Drug: Rosiglitazone (peroxisome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (peroxisome proliferator-activated receptor agonist)
Trial: 10640259
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg zolmitriptan
Trial: 18541561
Drug: Sesame oil
RxNorm normalized name: Sesame Oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sesame oil muffin consumption (sesamin, 94 mg; sesamolin, 42 mg)
Trial: 15325678
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 10.4 g/d of fiber
Trial: 15325678
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 30.5 g/d of fiber
Trial: 9287967
Drug: Octreotide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (200 micrograms daily)
Trial: 8394061
Drug: Granisetron (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (2 mg once a day for 6 consecutive days)
Trial: 8394061
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiemetic treatment)
Trial: 2872260
Drug: Treatment phase
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment phase completion
Trial: 29238506
Drug: Gabapentin, titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin, titrated from 300 mg/day to a maximum of 900 mg/day
Trial: 29238506
Drug: Topiramate, titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate, titrated from 50 mg/day to a maximum of 100 mg/day
Trial: 25494032
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate supplementation (50 mg · kg·fat‐free‐mass⁻¹ · day⁻¹; n = 7)
Trial: 17207671
Drug: Regular physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular physical therapy
Trial: 21692299
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (compound general anesthesia with meridian points)
Trial: 21692299
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (compound general anesthesia with placebo points)
Trial: 10684705
Drug: Paclitaxel-containing chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel-containing chemotherapy
Trial: 8360132
Drug: Loracarbef 400
RxNorm normalized name: loracarbef 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loracarbef 400 mg bd
Trial: 8360132
Drug: Doxycycline 200
RxNorm normalized name: doxycycline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 200 mg for the first dose followed by 100 mg od
Trial: 3739357
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg theophyllinethylendiamine (Euphyllin)
Trial: 3739357
Drug: Combined medication
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined medication consisting of 25 mg theophyllin, 85 mg etophyllin, 30 mg papaverine and 0.1 mg atropine methylnitrate (Perphyllon)
Trial: 24702786
Drug: Comprehensive mental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive mental intervention (support, counselling, music, massage plus conventional therapy)
Trial: 24702786
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (three‐cavity gastric tube, fasting, parenteral/enteral nutrition, routine care, health guidance)
Trial: 17658101
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral administration of a placebo medication and preincision local infiltration of 40 mL of 0.5 per cent bupivicaine at trocar sites
Trial: 17658101
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral administration of 50 mg of rofecoxib
Trial: 17658101
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral administration of 50 mg of rofecoxib and preincision local infiltration of 40 mL of 0.5 per cent bupivicaine
Trial: 17658101
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral administration of a placebo medication
Trial: 11470697
Drug: timolol gel
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: timolol gel 0.5%
Trial: 10085699
Drug: Duration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration of nephropathy, duration of renal treatment, duration of dialysis treatment
Trial: 24433231
Drug: I Can
RxNorm normalized name: DIPHENHYDRAMINE HYDROCHLORIDE 25 mg ORAL TABLET [Help I cant Sleep]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I Can Cope (4 sessions: learning about cancer; understanding cancer treatments; relieving cancer pain; keeping well in mind and body)
Trial: 24433231
Drug: Wellness intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wellness intervention (4 sessions: humor, meditation, relaxation, and music therapy)
Trial: 23185761
Drug: Youdujing (YDJ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Youdujing (YDJ) external lotion and YDJ cream
Trial: 23185761
Drug: Youdujing (YDJ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Youdujing (YDJ) treatment
Trial: 20473630
Drug: Ribonuclease-enriched lactoferrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribonuclease-enriched lactoferrin (R-ELF) supplementation (2 × 125 mg/day)